•  
  •  
 

Policies

Contents

Philosophy of Clinical Neuroscience & Immunology

Clinical Neuroscience & Immunology was started because the founding editors harbor a deep desire to contribute to an expansion of dialogue of clinical and translational neuroimmunology. The journal’s north star is to provide an independent, open-access publication space for interesting neuroimmunology and other clinical neuroscience reports, and in doing so, to perhaps identify observations leading to hypotheses that will impact the future of neuroscience research and therapy. We also intend to have the publications contribute to a potential real-world, searchable registry of neuroimmunology cases.

The journal is intended to retain a degree of plasticity as it grows, to allow change as needed to best serve the clinical neurosciences. The editorial board appreciates the potential of growth as a diamond open-access entity and will adjust participation based on workload to balance a successful volunteer workforce with freedom from advertisement, membership, and publication fees.

For more information, please check the updated aims and scope for Clinical Neuroscience & Immunology Aims and Scope

General Submission Rules

Submitted articles cannot have been previously published, nor be forthcoming in an archival journal or book (print or electronic). Please note: "publication" in a working-paper series does not constitute prior publication. In addition, by submitting material to Clinical Neuroscience & Immunology, the author is stipulating that the material is not currently under review at another journal (electronic or print) and that he or she will not submit the material to another journal (electronic or print) until the completion of the editorial decision process at Clinical Neuroscience & Immunology. If you have concerns about the submission terms for Clinical Neuroscience & Immunology, please contact the editors.

{ top }

Authorship

Anyone may submit an original article to be considered for publication in Clinical Neuroscience & Immunology provided the submitting author owns the copyright to the work being submitted or is authorized by the copyright owner or owners to submit the article. In our journal, authors are the owners of the copyrights to their works (an exception in the non-academic world to this might exist if the authors have, as a condition of employment, agreed to transfer copyright to their employer).

To be considered an author for a submission to Clinical Neuroscience & Immunology, one must contribute directly to significant portions of drafting and/or editing the manuscript, to include creation of the text or figures or significant discussion of strategy for layout and formatting. Please avoid adding colleagues who have not dedicated appropriate time and effort to the submission. Please avoid adding colleagues who have merely proofread the manuscript for grammar / typographical screening. The corresponding author must be able to account for each author’s contributions, if requested. Each listed author is expected to have read and reviewed the manuscript prior to submission.

{ top }

Plagiarism and Artificial Intelligence

Authors are required to submit original work and to summarize literature review components in their own words, without plagiarism. The editorial board reserves the right to utilize plagiarism screening applications for all submissions.

The spirit of Clinical Neuroscience & Immunology is to primarily provide a venue for educational case reports, and as such, there should not be significant need for artificial intelligence (AI). In the case of original research or reviews articles, if the authors utilize AI in the process of drafting a manuscript, this process must be declared in a cover letter, and the authors must specify which tools were utilized and to what extent. AI generated figures are strongly discouraged. If AI is utilized in the preparation of a manuscript, the authors must accept full responsibility for the accuracy and sourcing of any AI-associated content.

{ top }

Article Formats

Please review the options of article type as outlined below.

Case Report

Defined by 1 or 2 patients. Total word limit = 2000. Please include the following sections (authors may arrange the order of the clinical cases and review of literature as they see fit to optimize readability of the article):

Title (150-character limit, with spaces)

Abstract (500-word limit)

Declaration of conflicts of interest for each author*

Introduction

Clinical case (Include laboratory testing, imaging, and any additional relevant diagnostics)

Review of literature

Discussion

Figures and tables (limit to 3)

Figure and table legends

References cited

Case Series

Defined by at least 3 clinical cases. Total word limit = 3000. Follow similar format to Case Report (above).

Original Research Article

Total word limit = 5000. Please include the following sections:

Title (150-character limit, with spaces)

Abstract (500-word limit)

Declaration of conflicts of interest for each author*

Introduction

Results

Discussion

Materials and Methods

Figures and tables (limit to 3)

Figure and table legends

References cited

Narrative Review

Total word limit = 5000. Reviews are by invitation, and format is determined by the editorial board on a case-by-case basis.

Editorial/commentary

Total word limit =1500. Format to be determined at the discretion of the editorial board. *In the absence of conflict of interest, all submissions must still include a statement of no conflict of interest for each author.

{ top }

Formatting Requirements

Clinical Neuroscience & Immunology has no general rules about the formatting of articles upon initial submission beyond the sections of the report and the word count limitations, as posted. There are, however, rules governing the formatting of the final submission. See Final Manuscript Preparation Guidelines for details. Although bepress can provide limited technical support, it is ultimately the responsibility of the author to produce an electronic version of the article as a high-quality PDF (Adobe's Portable Document Format) file, or a Microsoft Word, WordPerfect or RTF file that can be converted to a PDF file.

It is understood that the current state of technology of Adobe's Portable Document Format (PDF) is such that there are no, and can be no, guarantees that documents in PDF will work perfectly with all possible hardware and software configurations that readers may have.

{ top }

Quality Control

Each submitted article will be assigned two content reviewers with appropriate clinical and/or research experience, and one handling editor, to evaluate the submission. The editor-in-chief (EIC) and associate editor-in-chief (AEIC) may serve as handling editor if the submission aligns with clinical expertise or additional editors are unable to provide timely handling of the submission.

As the journal launches and grows, there are expected to be submissions from individuals within the review and editorial boards. As such, the following workflow has been developed to ensure quality and integrity of the review process.

1. Any member of the review board or editorial board may not be involved with the peer review process of a manuscript submission for which that individual qualifies as an author.

2. In the case of internally submitted articles (authors include members of the review or editorial boards), at least one reviewer must be external to the affiliated department of the authors. If two external reviewers cannot be assigned, then an internal reviewer may serve as the second reviewer. An external editor will be assigned to all internally submitted articles.

3. All editors may serve as reviewers.

For all submissions, reviewers will be blinded to authors and authors will be blinded to reviewers.

Assigned editor will serve as tiebreaker for submissions in which the reviewers do not agree on publication merit. If the assigned handling editor desires, input may be obtained from the EIC or AEIC regarding publication merit.

{ top }

Copyright and Open Access

Clinical Neuroscience & Immunology exists as a diamond open-access journal. This is defined as a journal that provides immediate free access to published issues. The authors retain copyright of the published material, and must agree to grant usage rights to others using an open license (Creative Commons CC BY-NC-ND 4.0, or equivalent). This means reusers must give credit to the creator of the content (the authors), and are permitted to copy and distribute the material in any medium or format in unadapted form and for noncommercial purposes only. This permits any user to read, download, copy, distribute, print, search, or link to the full texts of articles, or otherwise use them for any other lawful purpose.

Creative Commons licensing information may be included in each published issue, such as:

This work is licensed under CC BY-NC-ND 4.0

{ top }

Fees / Cost of Publication

As a diamond open-access journal, Clinical Neuroscience & Immunology will have no associated costs for manuscript submission.

{ top }

Data Availability

All figures and tables must represent accurate data collection, and the corresponding author is responsible for ensuring accuracy and validity of submitted data. Large data sets, beyond clinical figures or tables, must be made fully available as supplemental material.

Use

Users of the CORE Scholar website and/or software agree not to misuse the CORE Scholar service or software in any way.

The failure of CORE Scholar to exercise or enforce any right or provision in the policies or the Submission Agreement does not constitute a waiver of such right or provision. If any term of the Submission Agreement or these policies is found to be invalid, the parties nevertheless agree that the court should endeavor to give effect to the parties' intentions as reflected in the provision, and the other provisions of the Submission Agreement and these policies remain in full force and effect. These policies and the Submission Agreement constitute the entire agreement between CORE Scholar and the Author(s) regarding submission of the Article.

{ top }